Trade Summary

9 months ago, Baker Bros. Advisors LP, serving as Dir at Madrigal Pharmaceuticals, Inc. (MDGL), purchased 97,065 shares at $380.58 per share, for a total transaction value of $36,941,197.00. Following this transaction, Baker Bros. Advisors LP now holds 1,947,968 shares of MDGL.

This purchase represents a 5.00% increase in Baker Bros. Advisors LP's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, August 18, 2025 and publicly disclosed via SEC Form 4 filing on Wednesday, August 20, 2025 at 6:12 PM ET, 2 days after the trade was made.

Madrigal Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.